Related references
Note: Only part of the references are listed.Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse
Vanessa Cropley et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
Identification of the mRNA Expression Status of the Dopamine D2 Receptor and Dopamine Transporter in Peripheral Blood Lymphocytes of Schizophrenia Patients
Liang Liu et al.
PLOS ONE (2013)
Life expectancy and cardiovascular mortality in persons with schizophrenia
Thomas M. Laursen et al.
CURRENT OPINION IN PSYCHIATRY (2012)
Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity
Gustavo E. A. Brito-Melo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Incidence of Schizophrenia and Other Psychoses in England, 1950-2009: A Systematic Review and Meta-Analyses
James B. Kirkbride et al.
PLOS ONE (2012)
Magnetic Resonance Imaging Predictors of Treatment Response in First-Episode Schizophrenia
Philip R. Szeszko et al.
SCHIZOPHRENIA BULLETIN (2012)
The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders
Clelia Pellicano et al.
Current Neuropharmacology (2011)
Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?
M. Urhan-Kucuk et al.
MOLECULAR BIOLOGY REPORTS (2011)
Analysis of Whole Genome Biomarker Expression in Blood and Brain
Brandi Rollins et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2010)
Defining the transcriptome and proteome in three functionally different human cell lines
Emma Lundberg et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder
K. C. L. Torres et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder
J. van Os et al.
PSYCHOLOGICAL MEDICINE (2009)
How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes
Yanfang Guo et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2008)
Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays
Galina P. Kirillova et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Verification of proposed peripheral biomarkers in mononuclear cells of individuals with schizophrenia
Yuanrong Yao et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Neuroimaging and other neurobiological indices in schizophrenia: relationship to measurement of functional outcome
John L. Waddington
BRITISH JOURNAL OF PSYCHIATRY (2007)
D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+-T cells
EM Boneberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Over-expression of dopamine D-2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers
A Zvara et al.
DISEASE MARKERS (2005)
Lymphocytes as a neural probe: potential for studying psychiatric disorders
A Gladkevich et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Twenty-Year Course of Schizophrenia: The Madras Longitudinal Study
R. Thara
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2004)
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome
SP Singh et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
Decreased levels of dopamine D-3 receptor mRNA in schizophrenic and bipolar patients
M Vogel et al.
NEUROPSYCHOBIOLOGY (2004)
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis
R Emsley et al.
SCHIZOPHRENIA RESEARCH (2003)
Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study
F McKenna et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Possible implications of the dopamine D-3 receptor in schizophrenia and in antipsychotic drug actions
JC Schwartz et al.
BRAIN RESEARCH REVIEWS (2000)
Share Paper
